Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 8Gastrointestinal 4Genitourinary 2Breast 2Thoracic 1Head & Neck 1Endocrine 1

Conditions

Lymphatic Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Lymph Node Excision × Gastrointestinal × Clear all
NCT01807936 2023-07-20

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

Fudan University

Phase NA Completed
400 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03796819 2021-12-09

LND for ICC

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Completed
260 enrolled
Gastrointestinal

Lymphatic Metastasis, Cholangiocarcinoma

NCT04764240 2021-02-23

Precisely Estimation of the Prognostic Value of Lymph Node in ESCC

Shanghai Cancer Hospital, China

Completed
3,700 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02031952 2014-01-09

Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma

Sun Yat-sen University

Phase NA Completed
87 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡